1 rrence of laryngeal lesions with the risk of airways obstruction.

2 urces for COPD patients with moderate/severe airways obstruction.

3 the same time that the FEV1 revealed ongoing airways obstruction.

4 ver, only asthma is associated with variable airways obstruction.

5 imilar for patients with concomitant chronic airways obstruction.

6 uggest that excessive mucin secretion causes airways obstruction and inflammation.

7 ystals, airway fibrosis, eotaxin production, airways obstruction, and nonspecific AHR.

8 ty is mostly caused by bronchiectasis, small airways obstruction, and progressive respiratory impairm

9          Control and COPD subjects with mild airways obstruction (baseline FEV(1) >/= 50% predicted)

10 ry disease that is characterized by variable airways obstruction caused by acute and chronic bronchia

11 gic agonist bronchodilators to patients with airways obstruction commonly results in transient decrea

12 s had severe Brasfield scores (9.0 +/- 3.2), airways obstruction (FEV1 25.6 +/- 5.6% predicted, FEF(2

13 piratory volume in 1 s [FEV1]) and increased airways obstruction (FEV1 as a percentage of forced vita

14 structural component in determining variable airways obstruction in asthma.

15 Although asthma is characterized by variable airways obstruction, most studies of asthma phenotypes a

16 y subjects, patients with moderate-to-severe airways obstruction receive an increased dose from ultra